MY ACCOUNT | NEWSLETTER |

Doc.com Expands U.S. Rollout with Florida Launch, Advancing AI-Powered Blockchain Secured Healthcare Access


Doc.com, the pioneering healthcare technology company redefining access to care through artificial intelligence and blockchain integration, today announced the launch of its telemedicine platform in Florida as part of its ongoing United States expansion. The Florida rollout marks a significant milestone in the company’s multi-phase national growth strategy.

Through a seamless mobile experience, Florida residents can now connect with licensed healthcare professionals within the state for secure, convenient telehealth consultations. The platform leverages AI-assisted tools designed to support clinical workflows and enhance provider decision-making, personalize care pathways, and optimize provider efficiency, while blockchain-based infrastructure designed to enhance transparency and data integrity, transparency, and patient control over medical records.

As part of its introductory experience, new users may access complimentary teleconsultation, available in eligible jurisdictions and subject to applicable regulations. These minutes may be used across one or multiple sessions as part of an initial trial. Subsequent consultations are available at standard rates.

Complimentary consultation time does not apply to emergency services and does not create a patient-provider relationship until formally established in accordance with applicable state laws.

“Florida represents a critical step in our U.S. expansion strategy,” said Charles Nader, CEO and Founder of Doc.com. “We are building a healthcare ecosystem where technology enhances human care, making it more accessible, more transparent, and more intelligent. Our AI-driven infrastructure supports providers while empowering patients with secure, affordable access to healthcare services.”

Doc.com’s broader U.S. rollout began with Phase 1 launches in West Virginia and continues through additional phases across 2026, subject to regulatory approvals and operational readiness, with nationwide availability targeted for early 2027. Florida’s activation strengthens the company’s footprint in high-demand markets and reinforces its commitment to scaling accessible care across diverse communities.

Beyond telemedicine, Doc.com is building a vertically integrated healthcare ecosystem that connects physical health, mental health, pharmacy services, veterinary care, and education within one unified platform. Its blockchain layer is designed to support secure medical record management, AI-enhanced diagnostics, and efficient healthcare transactions, creating a transparent and interoperable system.

About Doc.com

Doc.com is a healthcare technology company building the future of AI-driven healthcare solutions. The company accelerates the evolution of healthcare through a vertically integrated ecosystem that connects telemedicine, mental health support, veterinary care, pharmacy, and education in one seamless platform. Doc.com’s AI-powered technology enhances diagnostics, personalizes treatment, and enables medication delivery, while blockchain technology ensures transparency, security, and trust. With a mission to make access to care more equitable and sustainable, Doc.com is committed to advancing health as a human right by providing affordable, privacy-compliant, and technology-enabled healthcare solutions to communities worldwide.


Source: www.doc.com

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Dr. Eugene White Receives Fulbright Specialist Award to Advance Dairy Reproductive Education in Tanzania

Like0
Dislike0

Tartar Shield Launches “Second Smile” Initiative Integrating Preventive Dental Care Into Shelter Adoptions for 120+ Dogs in Recognition of National Pet Dental Health Awareness Month

Like0
Dislike0

Diagnosis and Surgical Correction of a Conjunctivopalpebral Dermoid in a Cat

Like0
Dislike0

Prevalence of Dermatological Presentations of Canine Leishmaniasis in a Nonendemic Area: A Retrospective Study of 100 Dogs

Like0
Dislike0

Adipose-Derived Stem Cells in Veterinary Medicine: Characterization and Therapeutic Applications

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top